Bristol-Myers Squibb
BMY
#189
Rank
C$162.94 B
Marketcap
C$79.79
Share price
1.18%
Change (1 day)
21.98%
Change (1 year)

Market capitalization of Bristol-Myers Squibb (BMY)

Market cap: C$162.94 Billion

As of June 2026 Bristol-Myers Squibb has a market cap of C$162.94 Billion. This makes Bristol-Myers Squibb the world's 189th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Bristol-Myers Squibb from 1996 to 2026

End of year Market Cap

Year Marketcap Change
2026C$162.94 B6.97%
2025C$152.33 B-9.26%
2024C$167.87 B21.23%
2023C$138.47 B-33.29%
2022C$207.58 B17.69%
2021C$176.37 B-1.32%
2020C$178.72 B-4.31%
2019C$186.78 B62.44%
2018C$114.99 B-8.81%
2017C$126.09 B-3.92%
2016C$131.24 B-17.19%
2015C$158.50 B39.98%
2014C$113.23 B21.96%
2013C$92.84 B75.76%
2012C$52.82 B-13.04%
2011C$60.74 B35.07%
2010C$44.97 B-0.95%
2009C$45.40 B-18.87%
2008C$55.96 B7.16%
2007C$52.22 B-13.14%
2006C$60.12 B14.83%
2005C$52.35 B-12.61%
2004C$59.91 B-16.76%
2003C$71.97 B0.76%
2002C$71.42 B-55.19%
2001C$159.41 B-26.33%
2000C$216.40 B18.01%
1999C$183.37 B-10.36%
1998C$204.58 B52.36%
1997C$134.27 B79.76%
1996C$74.70 B

End of Day market cap according to different sources

On Jun 6th, 2026 the market cap of Bristol-Myers Squibb was reported to be:

C$162.94 Billion
by Nasdaq info icon info icon
C$162.94 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Johnson & Johnson
JNJ
C$780.70 B 379.12%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
C$396.54 B 143.36%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
C$206.78 B 26.90%๐Ÿ‡บ๐Ÿ‡ธ USA
AbbVie
ABBV
C$559.36 B 243.28%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
C$1.405 T 762.71%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
C$262.87 B 61.33%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
C$150.15 B-7.85%๐Ÿ‡ซ๐Ÿ‡ท France
Biogen
BIIB
C$40.18 B-75.34%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
C$415.66 B 155.09%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
C$401.80 B 146.59%๐Ÿ‡ฌ๐Ÿ‡ง UK